<?xml version="1.0" encoding="utf-8" standalone="yes"?>
<?xml-stylesheet type="text/xsl" href="/css/apdocuments/ap-case.xsl"?>
<apCase>
  <creationDate>2019-07-17</creationDate>
  <apCaseHeader>
    <fileNumbers>
      <fileNumber>3-18778</fileNumber>
    </fileNumbers>
    <respondents>
      <respondent>Ampal-American Israel Corporation</respondent>
      <respondent>Robertson Global Health Solutions Corporation</respondent>
      <respondent>Sanguine Corporation</respondent>
    </respondents>
    <caseLink>/litigation/apdocuments/ap-3-18778.xml</caseLink>
  </apCaseHeader>
  <releaseItem>
    <date>2018-09-17</date>
    <releaseNumber>34-84178</releaseNumber>
    <otherReleaseNumbers />
    <title>Order Instituting Administrative Proceedings and Notice of Hearing Pursuant to Section 12(j) of the Securities Exchange Act of 1934</title>
    <secLink>/litigation/admin/2018/34-84178.pdf</secLink>
  </releaseItem>
  <releaseItem>
    <date>2018-10-01</date>
    <releaseNumber>34-84332</releaseNumber>
    <otherReleaseNumbers />
    <title>Order Making Findings and Revoking Registration of Securities Pursuant to Section 12(j) of the Securities Exchange Act of 1934 as to Robertson Global Health Solutions Corporation</title>
    <secLink>/litigation/admin/2018/34-84332.pdf</secLink>
  </releaseItem>
  <releaseItem>
    <date>2019-02-25</date>
    <releaseNumber>34-85195</releaseNumber>
    <otherReleaseNumbers />
    <title>Order to Show Cause</title>
    <secLink>/litigation/opinions/2019/34-85195.pdf</secLink>
  </releaseItem>
  <releaseItem>
    <date>2019-07-16</date>
    <releaseNumber>34-86388</releaseNumber>
    <otherReleaseNumbers />
    <title>Opinion of the Commission as to Ampal-American Israel Corporation and Sanguine Corporation</title>
    <secLink>/litigation/opinions/2019/34-86388.pdf</secLink>
  </releaseItem>
</apCase>